identification universal group b streptococcus vaccine multiple genome screen
group b streptococcus cbs multiserotype bacterial pathogen representing major cause life-threatening infections newborns develop broadly protective vaccine analyzed genome sequences eight gbs isolates cloned tested surface proteins vaccines four proteins elicited protection mice combination proved highly protective large panel strains including circulating serotypes protection also correlated antigen accessibility bacterial surface induction opsonophagocytic antibodies multigenome analysis screening described represent powerful strategy identifying potential vaccine candidates highly variable pathogens
